- Home
- ZM vs TEVA Comparison
ZM vs TEVA Comparison
Compare ZM & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZM
- TEVA
- Stock Information
- Founded
- ZM 2011
- TEVA 1901
- Country
- ZM United States
- TEVA Israel
- Employees
- ZM N/A
- TEVA N/A
- Industry
- ZM Computer Software: Programming Data Processing
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- ZM Technology
- TEVA Health Care
- Exchange
- ZM Nasdaq
- TEVA Nasdaq
- Market Cap
- ZM 23.9B
- TEVA 20.1B
- IPO Year
- ZM 2019
- TEVA N/A
- Fundamental
- Price
- ZM $77.99
- TEVA $16.97
- Analyst Decision
- ZM Buy
- TEVA Strong Buy
- Analyst Count
- ZM 27
- TEVA 8
- Target Price
- ZM $86.12
- TEVA $25.00
- AVG Volume (30 Days)
- ZM 2.6M
- TEVA 11.1M
- Earning Date
- ZM 08-20-2025
- TEVA 07-30-2025
- Dividend Yield
- ZM N/A
- TEVA N/A
- EPS Growth
- ZM 23.84
- TEVA N/A
- EPS
- ZM 3.33
- TEVA N/A
- Revenue
- ZM $4,698,914,000.00
- TEVA $16,616,000,000.00
- Revenue This Year
- ZM $6.12
- TEVA $5.69
- Revenue Next Year
- ZM $3.27
- TEVA N/A
- P/E Ratio
- ZM $23.30
- TEVA N/A
- Revenue Growth
- ZM 2.98
- TEVA 3.82
- 52 Week Low
- ZM $55.06
- TEVA $12.47
- 52 Week High
- ZM $92.80
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- ZM 44.26
- TEVA 48.95
- Support Level
- ZM $77.12
- TEVA $16.82
- Resistance Level
- ZM $78.56
- TEVA $17.73
- Average True Range (ATR)
- ZM 1.27
- TEVA 0.55
- MACD
- ZM -0.42
- TEVA -0.13
- Stochastic Oscillator
- ZM 28.38
- TEVA 25.14
About ZM Zoom Video Communications Inc.
Zoom Video Communications provides a communications platform that connects people through video, voice, chat, and content sharing. The company's cloud-native platform enables face-to-face video and connects users across various devices and locations in a single meeting. Zoom, which was founded in 2011 and is headquartered in San Jose, California, serves companies of all sizes from all industries around the world.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.